BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17494250)

  • 1. Care for immigrants with end-stage renal disease in Houston: a comparison of two practices.
    Sheikh-Hamad D; Paiuk E; Wright AJ; Kleinmann C; Khosla U; Shandera WX
    Tex Med; 2007 Apr; 103(4):54-8, 53. PubMed ID: 17494250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Care of undocumented individuals with ESRD: a national survey of US nephrologists.
    Hurley L; Kempe A; Crane LA; Davidson A; Pratte K; Linas S; Dickinson LM; Berl T
    Am J Kidney Dis; 2009 Jun; 53(6):940-9. PubMed ID: 19327878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing VA and private sector healthcare costs for end-stage renal disease.
    Hynes DM; Stroupe KT; Fischer MJ; Reda DJ; Manning W; Browning MM; Huo Z; Saban K; Kaufman JS;
    Med Care; 2012 Feb; 50(2):161-70. PubMed ID: 21945972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Scheduled vs Emergency-Only Dialysis With Health Outcomes and Costs in Undocumented Immigrants With End-stage Renal Disease.
    Nguyen OK; Vazquez MA; Charles L; Berger JR; Quiñones H; Fuquay R; Sanders JM; Kapinos KA; Halm EA; Makam AN
    JAMA Intern Med; 2019 Feb; 179(2):175-183. PubMed ID: 30575859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of a case manager-driven emergent dialysis program.
    Weaver CS; Myers IJ; Huffman G; Vohito R; Herceg D
    Prof Case Manag; 2012; 17(1):24-8. PubMed ID: 22146639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of depression on health care utilization in patients with end-stage renal disease treated with hemodialysis.
    Abbas Tavallaii S; Ebrahimnia M; Shamspour N; Assari S
    Eur J Intern Med; 2009 Jul; 20(4):411-4. PubMed ID: 19524185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom burden and quality of life in end-stage renal disease: a study of 179 patients on dialysis and palliative care.
    Yong DS; Kwok AO; Wong DM; Suen MH; Chen WT; Tse DM
    Palliat Med; 2009 Mar; 23(2):111-9. PubMed ID: 19153131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergent Dialysis and its Impact on Quality of Life in Undocumented Patients with End-Stage Renal Disease.
    Hogan AN; Fox WR; Roppolo LP; Suter RE
    Ethn Dis; 2017 Jan; 27(1):39-44. PubMed ID: 28115820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ESRD uninsured matter.
    Williams ME
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):67-74. PubMed ID: 17200045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis for undocumented immigrants in the United States.
    Rodriguez RA
    Adv Chronic Kidney Dis; 2015 Jan; 22(1):60-5. PubMed ID: 25573514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of hemodialysis in Iran.
    Arefzadeh A; Lessanpezeshki M; Seifi S
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):307-11. PubMed ID: 19237828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in health care spending for immigrants in the United States.
    Stimpson JP; Wilson FA; Eschbach K
    Health Aff (Millwood); 2010; 29(3):544-50. PubMed ID: 20150234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost analysis and health-related quality of life of home and self-care satellite haemodialysis.
    Malmström RK; Roine RP; Heikkilä A; Räsänen P; Sintonen H; Muroma-Karttunen R; Honkanen E
    Nephrol Dial Transplant; 2008 Jun; 23(6):1990-6. PubMed ID: 18223263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.